Sfe Investment Counsel Has Lifted By $300,120 Its Bristol Myers Squibb Co (BMY) Position; Rent A Center (RCII) Sentiment Is 0.84

May 24, 2018 - By Darrin Black

Rent-A-Center, Inc. (NASDAQ:RCII) Logo

Sfe Investment Counsel increased Bristol Myers Squibb Co (BMY) stake by 128.96% reported in 2017Q4 SEC filing. Sfe Investment Counsel acquired 4,920 shares as Bristol Myers Squibb Co (BMY)’s stock rose 2.38%. The Sfe Investment Counsel holds 8,735 shares with $535,000 value, up from 3,815 last quarter. Bristol Myers Squibb Co now has $85.56B valuation. The stock decreased 0.32% or $0.17 during the last trading session, reaching $52.33. About 1.56 million shares traded. Bristol-Myers Squibb Company (NYSE:BMY) has risen 11.37% since May 24, 2017 and is uptrending. It has underperformed by 0.18% the S&P500.

Rent A Center Inc (RCII) investors sentiment decreased to 0.84 in Q4 2017. It’s down -0.24, from 1.08 in 2017Q3. The ratio has dropped, as 76 hedge funds started new or increased equity positions, while 91 sold and reduced holdings in Rent A Center Inc. The hedge funds in our database now have: 64.20 million shares, up from 58.77 million shares in 2017Q3. Also, the number of hedge funds holding Rent A Center Inc in top ten equity positions decreased from 4 to 3 for a decrease of 1. Sold All: 29 Reduced: 62 Increased: 48 New Position: 28.

Rent-A-Center, Inc., together with its subsidiaries, leases household durable goods to clients on a rent-to-own basis. The company has market cap of $543.23 million. The firm operates through four divisions: Core U.S., Acceptance Now, Mexico, and Franchising. It has a 84.75 P/E ratio. It offers durable products, such as consumer electronics; appliances; computers, including tablets; smartphones; and furniture, including accessories under rental purchase agreements.

The stock decreased 2.02% or $0.21 during the last trading session, reaching $10.17. About 314,882 shares traded. Rent-A-Center, Inc. (RCII) has declined 3.97% since May 24, 2017 and is downtrending. It has underperformed by 15.52% the S&P500.

Ratings analysis reveals 0 of Rent-A-Center’s analysts are positive. Out of 3 Wall Street analysts rating Rent-A-Center, 0 give it “Buy”, 0 “Sell” rating, while 3 recommend “Hold”. RCII was included in 3 notes of analysts from October 13, 2016. The rating was downgraded by Raymond James to “Mkt Perform” on Tuesday, December 6. The stock of Rent-A-Center, Inc. (NASDAQ:RCII) has “Hold” rating given on Tuesday, December 13 by Loop Capital. The stock of Rent-A-Center, Inc. (NASDAQ:RCII) earned “Hold” rating by Jefferies on Thursday, October 13.

Analysts await Rent-A-Center, Inc. (NASDAQ:RCII) to report earnings on July, 25. They expect $0.04 EPS, up 500.00% or $0.05 from last year’s $-0.01 per share. RCII’s profit will be $2.14 million for 63.56 P/E if the $0.04 EPS becomes a reality. After $-0.08 actual EPS reported by Rent-A-Center, Inc. for the previous quarter, Wall Street now forecasts -150.00% EPS growth.

Engaged Capital Llc holds 12.94% of its portfolio in Rent-A-Center, Inc. for 8.98 million shares. Archer Capital Management L.P. owns 1.66 million shares or 7.1% of their US portfolio. Moreover, Arlington Value Capital Llc has 4.27% invested in the company for 4.07 million shares. The New York-based Elm Ridge Management Llc has invested 4.07% in the stock. Philadelphia Financial Management Of San Francisco Llc, a California-based fund reported 1.75 million shares.

More notable recent Bristol-Myers Squibb Company (NYSE:BMY) news were published by: Seekingalpha.com which released: “Bristol-Myers Squibb (BMY) Presents at UBS Global Healthcare Conference (Transcript)” on May 22, 2018, also Bizjournals.com with their article: “Why Big Pharma is finally discovering the Bay Area” published on May 23, 2018, Seekingalpha.com published: “Idera to collaborate with Bristol-Myers on study of IMO-2125/Yervoy combo in melanoma; shares up 4% premarket” on May 24, 2018. More interesting news about Bristol-Myers Squibb Company (NYSE:BMY) were released by: Bizjournals.com and their article: “How Bristol-Myers Squibb’s new Peninsula digs boost its battle to beat cancer” published on May 01, 2018 as well as Investorplace.com‘s news article titled: “Warren Buffett Loves TEVA Stock and You Should Too” with publication date: May 23, 2018.

Investors sentiment decreased to 0.94 in 2017 Q4. Its down 0.09, from 1.03 in 2017Q3. It turned negative, as 72 investors sold BMY shares while 526 reduced holdings. 106 funds opened positions while 457 raised stakes. 1.11 billion shares or 0.48% more from 1.11 billion shares in 2017Q3 were reported. Mcmillion Management Inc reported 62,981 shares. State Of Wisconsin Invest Board has 0.38% invested in Bristol-Myers Squibb Company (NYSE:BMY) for 2.24 million shares. Tctc Limited Company invested in 318,670 shares or 1.02% of the stock. Checchi Capital Advisers Ltd Llc reported 0.11% in Bristol-Myers Squibb Company (NYSE:BMY). Cutler Investment Counsel Lc owns 147,744 shares. Mcdaniel Terry And Co holds 5,450 shares. 26,094 are held by Ashfield Ptnrs Limited. Quantbot LP holds 0.05% or 7,987 shares in its portfolio. Andra Ap has invested 0.21% in Bristol-Myers Squibb Company (NYSE:BMY). Dodge And Cox holds 29.11M shares or 1.38% of its portfolio. Covington Advsrs Incorporated has 38,259 shares. Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Investment stated it has 10,600 shares or 0.01% of all its holdings. The Illinois-based Cibc Bank Usa has invested 0.08% in Bristol-Myers Squibb Company (NYSE:BMY). Wealthfront Inc accumulated 39,698 shares or 0.03% of the stock. Baystate Wealth Management Ltd invested in 1,468 shares.

Since December 12, 2017, it had 2 insider purchases, and 1 sale for $163,963 activity. Samuels Theodore R. II also bought $249,187 worth of Bristol-Myers Squibb Company (NYSE:BMY) shares. 4,770 shares were bought by Paliwal Dinesh C, worth $249,948. 5,300 shares were sold by Lynch Thomas J. Jr., worth $335,172 on Tuesday, December 12.

Among 22 analysts covering Bristol-Myers Squibb Company (NYSE:BMY), 6 have Buy rating, 2 Sell and 14 Hold. Therefore 27% are positive. Bristol-Myers Squibb Company had 87 analyst reports since July 28, 2015 according to SRatingsIntel. The firm earned “Underperform” rating on Friday, July 28 by BMO Capital Markets. The firm has “Buy” rating by Jefferies given on Wednesday, August 23. On Monday, July 10 the stock rating was maintained by Cowen & Co with “Hold”. The firm earned “Hold” rating on Monday, July 17 by Deutsche Bank. On Monday, September 18 the stock rating was maintained by Cowen & Co with “Hold”. The rating was maintained by Barclays Capital with “Equal Weight” on Tuesday, December 1. The stock of Bristol-Myers Squibb Company (NYSE:BMY) has “Hold” rating given on Thursday, August 11 by Berenberg. The rating was downgraded by Morgan Stanley on Tuesday, April 17 to “Equal-Weight”. The stock of Bristol-Myers Squibb Company (NYSE:BMY) earned “Neutral” rating by Bank of America on Monday, March 5. The rating was maintained by Jefferies on Thursday, August 27 with “Hold”.

Bristol-Myers Squibb Company (NYSE:BMY) Institutional Positions Chart

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>